• Shanghai HeartCare Medical Technology will hold its postponed extraordinary general meeting at Sealmedical Hall, Shanghai, on November 26, 2026.
• Shareholders will vote on nine board appointments for three-year terms, covering four executive, two non-executive and three independent non-executive directors.
• Proposals include appointing Zhang Han as an executive director and Lu Xubo as a non-executive director; seven directors face re-election.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai HeartCare Medical Technology Corporation Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261111-12409013), on November 11, 2026, and is solely responsible for the information contained therein.